Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia

dc.contributor.authorMyriam Atevalo-Herrera
dc.contributor.authorBladimiro Rincón‐Orozco
dc.contributor.authorJohn M. Gonzalez
dc.contributor.authorSonia Marcela Herrera-Arévalo
dc.contributor.authorElena Carrasquilla‐Agudelo
dc.contributor.authorPaula Andrea Serna‐Ortega
dc.contributor.authorSebastián Quiceno‐García
dc.contributor.authorNicolas Palacio‐Muñoz
dc.contributor.authorBrandon Rosero‐López
dc.contributor.authorErnesto Mondol‐Miranda
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T20:49:15Z
dc.date.available2026-03-22T20:49:15Z
dc.date.issued2024
dc.identifier.doi10.2139/ssrn.4746936
dc.identifier.urihttps://doi.org/10.2139/ssrn.4746936
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/84262
dc.language.isoen
dc.publisherRELX Group (Netherlands)
dc.relation.ispartofSSRN Electronic Journal
dc.sourceGlobal Vaccines (United States)
dc.subjectVaccination
dc.subjectVirology
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subjectAntibody response
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectAntibody
dc.subject2019-20 coronavirus outbreak
dc.subjectMedicine
dc.subjectBiology
dc.titleLongitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia
dc.typepreprint

Files